BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Abdallah M, Müllertz OO, Styles IK, Mörsdorf A, Quinn JF, Whittaker MR, Trevaskis NL. Lymphatic targeting by albumin-hitchhiking: Applications and optimisation. J Control Release 2020;327:117-28. [PMID: 32771478 DOI: 10.1016/j.jconrel.2020.07.046] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 9.7] [Reference Citation Analysis]
Number Citing Articles
1 Hou Y, Chen M, Bian Y, Zheng X, Tong R, Sun X. Advanced subunit vaccine delivery technologies: From vaccine cascade obstacles to design strategies. Acta Pharmaceutica Sinica B 2023. [DOI: 10.1016/j.apsb.2023.01.006] [Reference Citation Analysis]
2 Lei F, Li P, Chen T, Wang Q, Wang C, Liu Y, Deng Y, Zhang Z, Xu M, Tian J, Ren W, Li C. Recent advances in curcumin-loaded biomimetic nanomedicines for targeted therapies. Journal of Drug Delivery Science and Technology 2023. [DOI: 10.1016/j.jddst.2023.104200] [Reference Citation Analysis]
3 Mamuti M, Chen W, Jiang X. Nanotechnology‐Assisted Immunoengineering for Cancer Vaccines. Advanced NanoBiomed Research 2022. [DOI: 10.1002/anbr.202200080] [Reference Citation Analysis]
4 Zhao L, Tannenbaum A, Bakker ENTP, Benveniste H. Physiology of Glymphatic Solute Transport and Waste Clearance from the Brain. Physiology (Bethesda) 2022;37:0. [PMID: 35881783 DOI: 10.1152/physiol.00015.2022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Zhao B, Tang K, Zhao Y, Zhao W, Kumar V. Senkyunolide H Affects Cerebral Ischemic Injury through Regulation on Autophagy of Neuronal Cells via P13K/AKT/mTOR Signaling Pathway. Disease Markers 2022;2022:1-8. [DOI: 10.1155/2022/9211621] [Reference Citation Analysis]
6 Wang Q, Wang Z, Sun X, Jiang Q, Sun B, He Z, Zhang S, Luo C, Sun J. Lymph node-targeting nanovaccines for cancer immunotherapy. J Control Release 2022;351:102-22. [PMID: 36115556 DOI: 10.1016/j.jconrel.2022.09.015] [Reference Citation Analysis]
7 Wang Q, Jiang Q, Li D, Li C, Feng Y, Yang Z, He Z, Luo C, Sun J. Self-adaptive non-covalent albumin-binding near-infrared probe conjugates enabling precise sentinel lymph node metastasis illumination and primary tumor imaging. Nano Res . [DOI: 10.1007/s12274-022-4884-5] [Reference Citation Analysis]
8 Russell PS, Velivolu R, Maldonado Zimbrón VE, Hong J, Kavianinia I, Hickey AJR, Windsor JA, Phillips ARJ. Fluorescent Tracers for In Vivo Imaging of Lymphatic Targets. Front Pharmacol 2022;13:952581. [DOI: 10.3389/fphar.2022.952581] [Reference Citation Analysis]
9 Lee J, Kim D, Byun J, Wu Y, Park J, Oh YK. In vivo fate and intracellular trafficking of vaccine delivery systems. Adv Drug Deliv Rev 2022;186:114325. [PMID: 35550392 DOI: 10.1016/j.addr.2022.114325] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
10 Lau CYJ, Benne N, Lou B, Zharkova O, Ting HJ, Ter Braake D, van Kronenburg N, Fens MH, Broere F, Hennink WE, Wang JW, Mastrobattista E. Modulating albumin-mediated transport of peptide-drug conjugates for antigen-specific Treg induction. J Control Release 2022;348:938-50. [PMID: 35732251 DOI: 10.1016/j.jconrel.2022.06.025] [Reference Citation Analysis]
11 Mu X, Feng W, Li C, Li K, Li Y, Jing X, Lu Y, Zhou X, Li Z. Lighting up Self-Quenching Nanoaggregates with Protein Corona for Simultaneous Intraoperative Imaging and Photothermal Theranostics of Metastatic Cancer. Anal Chem 2022. [PMID: 35759408 DOI: 10.1021/acs.analchem.2c01462] [Reference Citation Analysis]
12 Singh N, Handa M, Singh V, Kesharwani P, Shukla R. Lymphatic targeting for therapeutic application using nanoparticulate systems. J Drug Target 2022;:1-34. [PMID: 35722764 DOI: 10.1080/1061186X.2022.2092741] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Song Y, Bugada L, Li R, Hu H, Zhang L, Li C, Yuan H, Rajanayake KK, Truchan NA, Wen F, Gao W, Sun D. Albumin nanoparticle containing a PI3Kγ inhibitor and paclitaxel in combination with α-PD1 induces tumor remission of breast cancer in mice. Sci Transl Med 2022;14:eabl3649. [PMID: 35507675 DOI: 10.1126/scitranslmed.abl3649] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
14 Gao W, Hu H, Dai L, He M, Yuan H, Zhang H, Liao J, Wen B, Li Y, Palmisano M, Traore MDM, Zhou S, Sun D. Structure‒tissue exposure/selectivity relationship (STR) correlates with clinical efficacy/safety. Acta Pharm Sin B 2022;12:2462-78. [PMID: 35646532 DOI: 10.1016/j.apsb.2022.02.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Harms M, Hansson RF, Carmali S, Almeida-Hernández Y, Sanchez-Garcia E, Münch J, Zelikin AN. Dimerization of the Peptide CXCR4-Antagonist on Macromolecular and Supramolecular Protraction Arms Affords Increased Potency and Enhanced Plasma Stability. Bioconjug Chem 2022. [PMID: 35293739 DOI: 10.1021/acs.bioconjchem.2c00034] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Sun D, Gao W, Hu H, Zhou S. Why 90% of clinical drug development fails and how to improve it? Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.02.002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 24] [Article Influence: 18.0] [Reference Citation Analysis]
17 Perazzolo S, Shireman LM, Shen DD, Ho RJY. Physiologically Based Pharmacokinetic Modeling of 3 HIV Drugs in Combination and the Role of Lymphatic System after Subcutaneous Dosing. Part 1: Model for the Free-Drug Mixture. J Pharm Sci 2022;111:529-41. [PMID: 34673093 DOI: 10.1016/j.xphs.2021.10.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Raveendran R, Dan Xu Y, Joshi N, Stenzel MH. Progress of albumin-polymer conjugates as efficient drug carriers. Pure and Applied Chemistry 2022;0. [DOI: 10.1515/pac-2021-2006] [Reference Citation Analysis]
19 Albayram MS, Smith G, Tufan F, Tuna IS, Bostancıklıoğlu M, Zile M, Albayram O. Non-invasive MR imaging of human brain lymphatic networks with connections to cervical lymph nodes. Nat Commun 2022;13:203. [PMID: 35017525 DOI: 10.1038/s41467-021-27887-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 15.0] [Reference Citation Analysis]
20 Ganesh AN, Garad S, Sanchez-felix MV. A biopharmaceutics perspective on oral peptide developability and drug delivery. Oral Delivery of Therapeutic Peptides and Proteins 2022. [DOI: 10.1016/b978-0-12-821061-1.00009-5] [Reference Citation Analysis]
21 Wang Q, Cai J, Xu Z, Huang S, Zhou R, Wang Z. Albumin-based Theranostic Nanosystem for Drug Controlled Release and Magnetic Resonance Imaging Guided Therapy. J Bionic Eng. [DOI: 10.1007/s42235-021-00109-5] [Reference Citation Analysis]
22 Ding Y, Li Z, Jaklenec A, Hu Q. Vaccine delivery systems toward lymph nodes. Adv Drug Deliv Rev 2021;179:113914. [PMID: 34363861 DOI: 10.1016/j.addr.2021.113914] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
23 Yu L, Hua Z, Luo X, Zhao T, Liu Y. Systematic interaction of plasma albumin with the efficacy of chemotherapeutic drugs. Biochim Biophys Acta Rev Cancer 2021;1877:188655. [PMID: 34780933 DOI: 10.1016/j.bbcan.2021.188655] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
24 Zhu M. Immunological perspectives on spatial and temporal vaccine delivery. Adv Drug Deliv Rev 2021;178:113966. [PMID: 34506868 DOI: 10.1016/j.addr.2021.113966] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Gao Y, Yue Y, Xiong S. An Albumin-Binding Domain Peptide Confers Enhanced Immunoprotection Against Viral Myocarditis by CVB3 VP1 Vaccine. Front Immunol 2021;12:666594. [PMID: 34630378 DOI: 10.3389/fimmu.2021.666594] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Han S, Mei L, Quach T, Porter C, Trevaskis N. Lipophilic Conjugates of Drugs: A Tool to Improve Drug Pharmacokinetic and Therapeutic Profiles. Pharm Res 2021;38:1497-518. [PMID: 34463935 DOI: 10.1007/s11095-021-03093-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
27 Chauhan A, Khan T, Omri A. Design and Encapsulation of Immunomodulators onto Gold Nanoparticles in Cancer Immunotherapy. Int J Mol Sci 2021;22:8037. [PMID: 34360803 DOI: 10.3390/ijms22158037] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
28 Walther R, Monge P, Pedersen AB, Benderoth A, Pedersen JN, Farzadfard A, Mandrup OA, Howard KA, Otzen DE, Zelikin AN. Per-glycosylation of the Surface-Accessible Lysines: One-Pot Aqueous Route to Stabilized Proteins with Native Activity. Chembiochem 2021;22:2478-85. [PMID: 33998129 DOI: 10.1002/cbic.202100228] [Reference Citation Analysis]
29 Trac N, Chung EJ. Overcoming physiological barriers by nanoparticles for intravenous drug delivery to the lymph nodes. Exp Biol Med (Maywood) 2021;:15353702211010762. [PMID: 33957802 DOI: 10.1177/15353702211010762] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
30 Mester S, Evers M, Meyer S, Nilsen J, Greiff V, Sandlie I, Leusen J, Andersen JT. Extended plasma half-life of albumin-binding domain fused human IgA upon pH-dependent albumin engagement of human FcRn in vitro and in vivo. MAbs 2021;13:1893888. [PMID: 33691596 DOI: 10.1080/19420862.2021.1893888] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
31 Ganesh AN, Heusser C, Garad S, Sánchez-félix MV. Patient-centric design for peptide delivery: Trends in routes of administration and advancement in drug delivery technologies. Medicine in Drug Discovery 2021;9:100079. [DOI: 10.1016/j.medidd.2020.100079] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
32 Feeney OM, Gracia G, Brundel DHS, Trevaskis NL, Cao E, Kaminskas LM, Porter CJH. Lymph-directed immunotherapy - Harnessing endogenous lymphatic distribution pathways for enhanced therapeutic outcomes in cancer. Adv Drug Deliv Rev 2020;160:115-35. [PMID: 33039497 DOI: 10.1016/j.addr.2020.10.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]